Influence of socioeconomic lifestyle factors and genetic polymorphism on type 2 diabetes occurrences among Tunisian Arab and Berber groups of Djerba Island

Pharmacogenomics and Personalized Medicine

Volumn 2, Issue 1, 2009, Pages 49-57

  Ouederni, Thouraya Baroudi ^a   Fadiel, Ahmed ^b,c   Stambouli, Nejla ^a   Scalize, Trudy J ^c   Maiz, Hedi Ben ^d   Abid, Hafaona Kammoun ^a   Bouhaha, Rim ^a   Sanchez Corona, Jose ^e   Hamza, Adel ^a,f   Benammar Elgaaied, Amel ^a  

^a FACULTÉ DES SCIENCES DE TUNIS   (Tunisia)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MEHARRY MEDICAL COLLEGE   (United States)

^d CHARLES NICOLLE HOSPITAL   (Tunisia)

^e INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^f University of Kentucky   (United States)

Author keywords

Arabs; Berbers; Djerba Island; Insulin; Insulin receptor; Insulin receptor substrate 1; Lifestyle; Polymorphism

Indexed keywords

INSULIN; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 1;

ADULT; ARAB; ARTICLE; CALORIC INTAKE; COMPARATIVE STUDY; CONSANGUINITY; CONTROL GROUP; CONTROLLED STUDY; EDUCATIONAL STATUS; ENVIRONMENTAL FACTOR; ETHNIC AND RACIAL GROUPS; ETHNIC DIFFERENCE; ETHNIC GROUP; FEMALE; FOOD INTAKE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HEREDITY; HUMAN; INTERVIEW; LIFESTYLE MODIFICATION; MACRONUTRIENT; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PHYSICAL ACTIVITY; POLYMERASE CHAIN REACTION; PREVALENCE; QUESTIONNAIRE; SMOKING; SOCIOECONOMICS; TUNISIA;

EID: 77953403434     PISSN: None     EISSN: 11787066     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. McCarthy MI, Froguel P. Genetic approaches to the molecular understanding of type 2 diabetes. Am J Physiol Endocrinol Metab. 2002;283:217-225.
2. Morton N, Lio E. Oligogenic linkage and map integration. In: Pawlowitzki IH, Edwards JH, Thompson EA, editors. Genetic Mapping of Disease Genes. 1st edition. San Diego, CA: Academic Press; 1997. p. 17-21.
3. De Meyts P. The diabetogenes concept of NIDDM. Adv Exp Med Biol. 1993;334:89-100.
4. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 1997;20:1183-1197.
5. Moller DE, Bjørbæk C, Vidal Puig A. Candidate genes for insulin resistance. Diabetes Care. 1996;19:396-400.
6. Hoban PR, Kelsey AM. Pst I polymorphism within the 3′ untranslated region of the insulin gene detectable by the polymerase chain reaction. Nucleic Acids Res. 1991;19:4576.
7. Taylor SI, Kadowaki T, Kadowaki HD, Cama C, Keon M. Mutations in insulin-receptor gene in insulin-resistant patients. Diabetes Care. 1990;13:257-279.
8. Taylor SI. Insulin action, insulin resistance and type 2 diabetes mellitus. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The Metabolic and Molecular Bases of Inherited Diseases. 8th edition. New York, NY: McGraw-Hill; 2001. p. 1433-1470.
9. Bennett ST, Todd AJ. Human type 1 diabetes and the insulin gene: principles of mapping polygenes. Annu Rev Genet. 1996;30:343-370.
10. Bennett ST, Lucassen AM, Gough SC, et al. Susceptibility to human type 1 diabetes at IDDM2 is determined by tandem repeat variation at the insulin gene minisatellite locus. Nat Genet. 1995;9:284-292.
11. Schrader AP, Zee RY, Morris BJ. Association analyses of NsiI RFLP of human insulin receptor gene in hypertensives. Clin Genet. 1996;49:74-78.
12. Imai YA, Fusco Y, Suzuki, et al. Variant sequences of insulin receptor substrate-1 in patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab. 1994;79:1655-1658.
13. Baroni MG, Arca F, Sentinelli F, et al. The G972R variant of the insulin receptor substrate-1 (IRS-1) gene, body fat distribution and insulinresistance. Diabetologia. 2001;44:367-372.
14. Gharbi M, Akrout M, Zouari B. Prevalence and risk factors of noninsulin-dependent diabetes mellitus in the rural and urban population of Tunisia. Rev Epidemiol Sante Publique. 2002;503:49-55.
15. Arfa I, Abid A, Malouche D, et al. Familial aggregation and excess maternal transmission of type 2 diabetes in Tunisia. Postgrad Med J. 2007;833:48-51.
16. Sánchez-Corona J, Flores-Martínez SE, Machorro-Lazo MV, et al. Polymorphisms in candidate genes for type 2 diabetes mellitus in a Mexican population with metabolic syndrome findings. Diabetes Res Clin Pract. 2004;63:47-55.
17. Vasarova de Courten B, de Courten M, Hanson RL, et al. Higher prevalence of type 2 diabetes metabolic syndrome and cardiovascular diseases in gypsies than in non-gypsies in Slovakia. Diabetes Res Clin Pract. 2003;62:95-103.
18. Knowler WC, Pettitt DJ, Saad MF, Bennett PH. Diabetes mellitus in the Pima Indians: incidence, risk factors and pathogenesis. Diabetes Metab Rev. 1990;6:1-27.
19. Arroyo P, Pardio J, Fernandez V, Vargas-Ancona L, Canul G, Loria A. Obesity and cultural environment in Yucatan region. Nutr Rev. 1999;57(5 Pt 2):S78-S82.
20. Gustincich S, Manfioletti G, Del Sal G, Schneider C, Carninci P. A fast method for high-quality genomic DNA extraction from whole human blood. Biotechniques. 1991;11:298-302.
21. Sambrook J, Fritsch EF, Maniatis T, editors. Molecular Cloning: A Laboratory Manual. 2nd edition. New York, NY: Cold Spring Harbor Laboratory Press; 1989. p. 9.1-9.62.
22. Saiki RK, Gelfand DH, Stoffel S, et al. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science. 1988;239:487-491.
23. Hoban PR, Kelsey AM. PstI polymorphism within the 3′ untranslated region of the insulin gene detectable by the polymerase chain reaction (INS), Nucleic Acids Res. 1991;19:45-76.
24. Schrader AP, Zee RY, Morris BJ. Association analyses of NsiI RFLP of human insulin receptor gene in hypertensives. Clin Genet. 1996;49:74-78.
25. Almind K, Bjorbaek C, Vestergaard H, Hansen T, Echwald S, Pedersen O. Aminoacid polymorphisms of insulin receptor substrate-1 in non-insulin-dependent diabetes mellitus. Lancet. 1993;342:828-832.
26. Cherni L, Pereira L, Goios A, et al. Y-chromosomal STR haplotypes in three ethnic groups and one cosmopolitan population from Tunisia. Forensic Sci Int. 2005:152:95-99.
27. Loueslati B, Cherni L, Khodjet-Elkhil H, et al. Islands inside an island: reproductive isolates on Jerba island. Am J Hum Biol. 2006;18:149-153.
28. Bennett ST, Lucassen AM, Gough SC, et al. Susceptibility to human type 1 diabetes at IDDM2 is determined by tandem repeat variation at the insulin gene minisatellite locus. Nat Genet. 1995;9:284-292.
29. Morgan R, Bishop A, Owens DR, Luzio SD, Peters JR, Rees A. Allelic variants at insulin-receptor and insulin gene loci and susceptibility to NIDDM in Welsh population. Diabetes. 1990;39:1479-1484.
30. Given BD, Mako ME, Tager HS, et al. Diabetes due to secretion of an abnormal insulin. N Engl J Med. 1980;302:129-135.
31. Seino S, Bell GI. Alternative splicing of human insulin receptor messenger RNA. Biochem Biophys Res Commun. 1989;159:312-316.
32. Engstrom G, Jerntorp I, Pessah-Rasmussen H, Hedblad B, Berglund G, Janzon L. Geographic distribution of stroke incidence within an urban population: relations to socioeconomic circumstances and prevalence of cardiovascular risk factors. Stroke. 2001;32:1098-1103.
33. Baroni MG, Arca M, Sentinelli F, et al. The G972R variant of the insulin receptor substrate-1 (IRS-1) gene, body fat distribution and insulin-resistance. Diabetologia. 2001;44:367-372.
34. Clausen JO, Hansen T, Bjorbaek C, et al. Insulin resistance: interactions between obesity and a common variant of insulin receptor substrate-1. Lancet. 1995;346:397-402.
35. Lei HH, Coresh J, Shuldiner AR, Boerwinkle E, Brancati FL. Variants of the insulin receptor substrate-1 and fatty acid binding protein 2 genes and the risk of type 2 diabetes, obesity, and hyperinsulinemia in African-Americans: the Atherosclerosis Risk in Communities Study. Diabetes. 1999;48:1868-1872.
36. Chuang LM, Lai CS, Yeh JI, Wu HP, Tai TY, Lin BJ. No association between the Gly971Arg variant of the insulin receptor substrate 1 gene and NIDDM in the Taiwanese population. Diabetes Care. 1996; 19:446-449.
37. van Dam RM, Hoebee B, Seidell JC, Schaap MM, Blaak EE, Feskens EJ. The insulin receptor substrate-1 Gly972Arg polymorphism is not associated with type 2 diabetes mellitus in two populationbased studies. Diabet Med. 2004;21:752-758.
38. Celi FS, Silver K, Walston J, Knowler WC, Bogardus C, Shuldiner AR. Lack of IRS-1 codon 513 and 972 polymorphism in Pima Indians. J Clin Endocrinol Metab. 1995;80:2827-2829.
39. Ura S, Araki E, Kishikawa H, et al. Molecular scanning of the insulin receptor substrate-1 (IRS-1) gene in Japanese patients with NIDDM: identification of five novel polymorphisms. Diabetologia. 1996;39:600-608.
40. Yacoubi Loueslati B, Ennafaa H, Ben Amor M, et al. [Mitochondrial DNA polymorphism reveals a genetic differentiation between ethnic groups in the population of Jerba]. Arch Inst Pasteur Tunis. 1998;75:9-18.
41. Andersson CM, Bjaras G, Tillgren P, Ostenson G. Local media monitoring in process evaluation. Experiences from the Stockholm Diabetes Prevention Programme. J Health Commun. 2007;3:269-283.
42. Bassuk SS, Manson JE. Epidemiological evidence for the role of physical activity in reducing risk of type 2 diabetes and cardiovascular disease. J Appl Physiol. 2005;99:1193-1204.